Publication | Closed Access

Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?

Preferential ImpairmentCancer ImmunosurveillanceMedicineT-regulatory CellImmunologyPathologyRegulatory T CellsImmune Checkpoint InhibitorAutoimmunityAugment Anti-tumor ImmunotherapyTolerance InductionImmunotherapyOncologyTumor MicroenvironmentCancer Research